39.1 USD
-0.41 (-1.04%)
39.1 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to BTSG. BTSG was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of BTSG get a neutral evaluation. Nothing too spectacular is happening here. BTSG is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year BTSG was profitable.
In the past year BTSG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BTSG reported negative net income in multiple years.
BTSG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BTSG has a Return On Assets (2.14%) which is comparable to the rest of the industry.
The Return On Equity of BTSG (7.13%) is better than 65.35% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.68%, BTSG is in line with its industry, outperforming 54.46% of the companies in the same industry.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.21%.
The last Return On Invested Capital (4.68%) for BTSG is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROIC | 4.68% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
BTSG has a Profit Margin (1.04%) which is in line with its industry peers.
BTSG's Operating Margin of 2.15% is in line compared to the rest of the industry. BTSG outperforms 49.51% of its industry peers.
BTSG's Operating Margin has improved in the last couple of years.
The Gross Margin of BTSG (12.30%) is worse than 69.31% of its industry peers.
BTSG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BTSG is destroying value.
BTSG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BTSG has more shares outstanding
The debt/assets ratio for BTSG has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.43 indicates that BTSG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.43, BTSG is in the better half of the industry, outperforming 70.30% of the companies in the same industry.
BTSG has a debt to FCF ratio of 9.17. This is a negative value and a sign of low solvency as BTSG would need 9.17 years to pay back of all of its debts.
The Debt to FCF ratio of BTSG (9.17) is comparable to the rest of the industry.
BTSG has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BTSG (1.36) is worse than 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Altman-Z | 3.43 |
ROIC/WACC0.52
WACC9.06%
2.3 Liquidity
BTSG has a Current Ratio of 1.79. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, BTSG is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
BTSG has a Quick Ratio of 1.38. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
BTSG has a Quick ratio (1.38) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
BTSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.02%, which is quite impressive.
Looking at the last year, BTSG shows a quite strong growth in Revenue. The Revenue has grown by 17.23% in the last year.
Measured over the past years, BTSG shows a very strong growth in Revenue. The Revenue has been growing by 20.01% on average per year.
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
3.2 Future
The Earnings Per Share is expected to grow by 43.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, BTSG will show a quite strong growth in Revenue. The Revenue will grow by 15.41% on average per year.
EPS Next Y97.42%
EPS Next 2Y53.4%
EPS Next 3Y45%
EPS Next 5Y43.45%
Revenue Next Year13.42%
Revenue Next 2Y14.04%
Revenue Next 3Y13.79%
Revenue Next 5Y15.41%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 38.33, which means the current valuation is very expensive for BTSG.
The rest of the industry has a similar Price/Earnings ratio as BTSG.
When comparing the Price/Earnings ratio of BTSG to the average of the S&P500 Index (27.00), we can say BTSG is valued slightly more expensively.
With a Price/Forward Earnings ratio of 30.21, BTSG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as BTSG.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.70, BTSG is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.33 | ||
| Fwd PE | 30.21 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as BTSG.
BTSG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.54 | ||
| EV/EBITDA | 21.34 |
4.3 Compensation for Growth
BTSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSG's earnings are expected to grow with 45.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y53.4%
EPS Next 3Y45%
5. Dividend
5.1 Amount
BTSG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
39.1
-0.41 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.18%
Inst Owner Change0%
Ins Owners2.49%
Ins Owner Change-0.1%
Market Cap7.05B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts84
Price Target41.89 (7.14%)
Short Float %7.73%
Short Ratio2.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.19%
PT rev (3m)39.6%
EPS NQ rev (1m)-1.72%
EPS NQ rev (3m)12.77%
EPS NY rev (1m)0.32%
EPS NY rev (3m)14.49%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.33 | ||
| Fwd PE | 30.21 | ||
| P/S | 0.57 | ||
| P/FCF | 25.54 | ||
| P/OCF | 20.19 | ||
| P/B | 3.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.34 |
EPS(TTM)1.02
EY2.61%
EPS(NY)1.29
Fwd EY3.31%
FCF(TTM)1.53
FCFY3.92%
OCF(TTM)1.94
OCFY4.95%
SpS68.83
BVpS10.08
TBVpS-5.95
PEG (NY)0.39
PEG (5Y)N/A
Graham Number15.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.14% | ||
| ROE | 7.13% | ||
| ROCE | 5.92% | ||
| ROIC | 4.68% | ||
| ROICexc | 4.83% | ||
| ROICexgc | 14.34% | ||
| OM | 2.15% | ||
| PM (TTM) | 1.04% | ||
| GM | 12.3% | ||
| FCFM | 2.22% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.36 | ||
| Debt/FCF | 9.17 | ||
| Debt/EBITDA | 5.55 | ||
| Cap/Depr | 40.71% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 1.44 | ||
| Cash Conversion | 78.31% | ||
| Profit Quality | 213.06% | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 3.43 |
F-Score7
WACC9.06%
ROIC/WACC0.52
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y97.42%
EPS Next 2Y53.4%
EPS Next 3Y45%
EPS Next 5Y43.45%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year13.42%
Revenue Next 2Y14.04%
Revenue Next 3Y13.79%
Revenue Next 5Y15.41%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year63.58%
EBIT Next 3Y28.96%
EBIT Next 5Y28.14%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%
BRIGHTSPRING HEALTH SERVICES / BTSG FAQ
Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a fundamental rating of 4 / 10 to BTSG.
Can you provide the valuation status for BRIGHTSPRING HEALTH SERVICES?
ChartMill assigns a valuation rating of 3 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Overvalued.
How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.
What is the financial health of BRIGHTSPRING HEALTH SERVICES (BTSG) stock?
The financial health rating of BRIGHTSPRING HEALTH SERVICES (BTSG) is 4 / 10.
What is the earnings growth outlook for BRIGHTSPRING HEALTH SERVICES?
The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 97.42% in the next year.